Coya Therapeutics (COYA) Stock Price, Quote, News & History | Benzinga

Coya Therapeutics Inc (COYA) Stock Price, Quote, News & History

COYANASDAQ

Trade with Public

Trade with Public

$5.10

0.142.90%

Last update: May 18, 9:41 AM

Earnings: Q1 2026 Earnings were released on Tue May 12th, before the market open

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$5.05

Close

-

Volume / Avg.

30.55K / 149.21K

Day Range

$5.05 - $5.18

52 Wk Range

3.71 - 7.75

Market Cap

$119.73M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

3.55%

Days to Cover

5.68

Recent Coya Therapeutics Inc News

EXCLUSIVE: Coya Therapeutics Investigational Combination Therapy With GLP-1 Shows Potential For Alzheimer's Disease

Coya's COYA 303 showed strong immune modulation and reduced inflammation in the brain, supporting its development for neurodegenerative diseases like Alzheimer's.

Vandana Singh

What's Going On With Coya Therapeutics Stock?

Shares of Coya Therapeutics are trading higher Monday morning. The company provided an update regarding the development of a new treatment for Amyotrophic Lateral Sclerosis.

Henry Khederian

Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers Following Monthly Dosing

Coya Therapeutics' Phase 2 study shows monthly LD IL-2 improves cognitive scores and reduces inflammation in Alzheimer's patients, with no serious adverse events.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-14.12M

Investing Cash Flow (TTM)

-2.05M

Financing Cash Flow (TTM)

31.36M

Free Cash Flow (TTM)

-14.12M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

15.19M

Analyst Trends and Forecast

2

Dec 25

4

Jan

2

Feb

4

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$65.62M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

11.38

PB Ratio (TTM)

2.38

Earnings Yield % (TTM)

-23.19%

Earnings Yield % (FWD)

-31.05%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.09

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$50.72M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.05

Close

-

Volume / Avg.

30.55K / 149.21K

Day Range

$5.05 - $5.18

52 Wk Range

3.71 - 7.75

Market Cap

$119.73M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

3.55%

Days to Cover

5.68

About

Sector

Health Care

Industry

Biotechnology

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chroni...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Coya Therapeutics (COYA) stock?

A

You can purchase shares of Coya Therapeutics (NASDAQ:COYA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Coya Therapeutics (COYA) competitors?

A

There are no as such competitors for Coya Therapeutics.

Q

What is the forecast, or price target, for Coya Therapeutics (COYA) stock?

A

Coya Therapeutics has a consensus price target of $17.86.

Q

What is the current price for Coya Therapeutics (COYA)?

A

The stock price for Coya Therapeutics (NASDAQ: COYA) is $5.104 last updated May 18, 2026 at 9:41 AM EDT.

Q

Does Coya Therapeutics (COYA) pay a dividend?

A

There are no upcoming dividends for Coya Therapeutics.

Q

When is Coya Therapeutics (NASDAQ:COYA) reporting earnings?

A

Coya Therapeutics does not have any upcoming earnings scheduled.

Q

Is Coya Therapeutics (COYA) going to split?

A

There is no upcoming split for Coya Therapeutics.

Q

What sector and industry does Coya Therapeutics (COYA) operate in?

A

Coya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.